Lupromax Pelumas Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lupromax Pelumas Indonesia Tbk. trades at Rp114 (market cap 72.8B, 1.16M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.3× Lupromax Pelumas Indonesia Tbk.'s market cap, and Lupromax Pelumas Indonesia Tbk. is more actively traded (1.16M versus 96.7K). Which is the better fit depends on your goals.
| LMAX | OBAT | |
|---|---|---|
Market Cap | 72.8B | 167.37B |
Volume | 1.16M | 96.7K |
Lot | 11.62K | 967 |
Turnover | 135.77M | 23.82M |
Average Price | 116.8 | 246.34 |
Value | 135.77M | 23.82M |
Indicative Equilibrium Price | 114 | 248 |
Indicative Equilibrium Volume | 427 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.
Read more on LMAX →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →